G65D (p.Gly65Asp) variant of GRM5 (P41594)
G65D (p.Gly65Asp) in GRM5 (P41594) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.63 / 1.
G65D (p.Gly65Asp) variant details
- p.Gly65Asp
- rs751888494
- ExAC rs751888494
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.627
- AlphaMissense 1.00
- MetaLR 0.58
- MetaSVM 0.24
- PolyPhen-2 1.00
- SIFT 0.00
- MutPred 0.74
- UniProt: Variant assessed as somatic; moderate impact.